Sharon Zhang

Statistics

Publications

Citations

1.2K

H-Index

Active since

2001

Affiliations

Bristol-Myers Squibb (United States)(Current)

Sharon Zhang is an author at Bristol-Myers Squibb (United States) specializing in antiviral pharmacology, antiretroviral therapy, and molecular virology.

Publications per year

2001–2023

Publications

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Richard J. Colonno, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2006 · 348 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Antimicrobial Agents and Chemotherapy · 2006 · 239 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Neighborhood characteristics in relation to diet, physical activity and overweight of Canadian children

Paul J. Veugelers, Fortune Sithole, Sharon Zhang et al. · International Journal of Pediatric Obesity · 2008 · 150 citations

Public Health, Child Health, Public Health Nutrition +17

Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage

Beata Nowicka-Sans, Tricia Protack, Zeyu Lin et al. · Antimicrobial Agents and Chemotherapy · 2016 · 65 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +17

<i>In Vivo</i> Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043

Nannan Zhou, Beata Nowicka-Sans, Sharon Zhang et al. · Antimicrobial Agents and Chemotherapy · 2010 · 54 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 19